NCT06095739View on ClinicalTrials.gov

Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

January 2, 2023

Study Completion Date

January 2, 2023

Conditions
Hair DiseasesAlopeciaHair Loss
Interventions
COMBINATION_PRODUCT

DA-OTC-002

"The topical formula of DA-OTC-002 was formed from 2 molecules: an alpha 1 agonist (synephrine) and a TAAR receptor agonist~A 1mL topical application of DA-OTC-002 was applied to a 10cm x 10xm target area of the right side of the scalp of each subject"

Trial Locations (1)

Unknown

Hospital Oscar Nicolau, Manaus

Sponsors
All Listed Sponsors
lead

Applied Biology, Inc.

INDUSTRY

NCT06095739 - Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 | Biotech Hunter | Biotech Hunter